Completed
An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer - CA209-9GY
Aggiornato:
15 giugno, 2026
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice
Completed
An Observational Study of Nivolumab in Participants With Advanced Kidney Cancer - CA209-9GY
Aggiornato:
15 giugno, 2026
|
ClinicalTrials.gov